Work

Targeting extra-gonadal androgens in castration-resistant prostate cancer

Year: 2014

Type: review

Source: The Journal of Steroid Biochemistry and Molecular Biology

DOI: 10.1016/j.jsbmb.2014.09.006

Authors: Emily Grist, Johann S. de Bono, Gerhardt Attard

Institutions: Royal Marsden NHS Foundation Trust, Institute of Cancer Research

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Amgen, Pfizer, AstraZeneca, GlaxoSmithKline, Merck, Novartis, Roche, Sanofi, Enzon Pharmaceuticals, Exelixis, Dendreon Pharmaceuticals, Cancer Research UK, National Institute for Health and Care Research, Prostate Cancer UK, Astellas Pharma, Ipsen, Genentech, Takeda Oncology, Janssen Biotech

Awards: G2519382346, G4874885190, G6183633728, G897306359

OpenAlex ID: W2035380640

FWCI: 0.399

Cites: 72

Cited by: 13

Related to: 10